Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Ed Cinca, Senior Vice President, Marketing & Patient Solutions, Novo Nordisk, said: We know that patients are looking for additional options for weight loss, and with [7.2 mg semaglutide] we are answering that call. Self-paying adults prescribed the 7.2 mg semaglutide are set to pay $399 per month, with commercially insured patients potentially paying a fraction of the price, at $25 per month, Novo said
Additional details about the SELECT trial will be shared at a scientific conference in 2023.
ArticlePubMed 50
Tirzepatide reduced energy intake versus placebo at week 3 (estimated treatment difference 524.6 kcal (95% confidence interval 648.1 to 401.0), P 4 kg)
US$ 25.88
US$ 28.70
US$ 21.09
US$ 20.15
US$ 29.43
